logo-large
  • Browse Categories

Publications by authors named "T Erngren"

Claim this Profile
T
Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction.
Elizabeth England, D Gareth Rees, Ian Christopher Scott, Sara Carmen, Denice T Y Chan, Teodor Erngren

Sci Rep· June 2023


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Epithelial Lining Fluid Partitioning of Systemically Administered Monoclonal Antibodies in Rats.
E Boger, T Erngren, B-M Fihn, E Leonard, K Rubin

J Pharm Sci· April 2023


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Possible Extraction of Drugs from Lung Tissue During Broncho-alveolar Lavage Suggest Uncertainty in the Procedure's Utility for Quantitative Assessment of Airway Drug Exposure.
E Bäckström, T Erngren, B-M Fihn, M W Sadiq, W Lindberg

J Pharm Sci· March 2022


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: